October is Breast Cancer Awareness Month! In the interest of breast cancer awareness month, we have put together a list of our most frequently read a

CO-NEWSLETTER-LOGO Oct2013
Revolade banner 728x90 R1
***

October is Breast Cancer Awareness Month!

In the interest of breast cancer awareness month, we have put together a list of our most frequently read articles on breast cancer published within the last 12 months.

Tumour size predicts long-term survival among women with lymph node-positive breast cancer
S.A. Narod
Vol. 19, No. 5 (2012)
http://www.current-oncology.com/index.php/oncology/article/view/1043/1013

Mindfulness-based stress reduction for breast cancer— a systematic review and meta-analysis
H. Cramer, R. Lauche, A. Paul, G. Dobos
Vol. 19, No. 5 (2012)
http://www.current-oncology.com/index.php/oncology/article/view/1016/1008

Size surprise? Tumour size, nodal status, and outcome after breast cancer
W.D. Foulkes
Vol. 19, No. 5 (2012)
http://www.current-oncology.com/index.php/oncology/article/view/1185/1005

Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases: the state of the art
M. Clemons, K.A. Gelmon, K.I. Pritchard, A.H.G. Paterson
Vol. 19, No. 5 (2012)
http://www.current-oncology.com/index.php/oncology/article/view/1011/1003

Endocrine therapy for postmenopausal women with hormone receptor–positive her2–negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: a Canadian consensus statement
K.I. Pritchard, K.A. Gelmon, D. Rayson, L. Provencher, Marc Webster, D. McLeod, S. Verma
Vol. 20, No. 1 (2013)
http://www.current-oncology.com/index.php/oncology/article/view/1316/1121

logo70

Multimed Inc.
Publisher of Current Oncology
www.multi-med.com

***
rethink col log

Rethink Breast Cancer is the first Canadian charity that focuses on awareness, support, research and advocacy specific to the needs of younger people concerned about and affected by breast cancer. Rethink’s pioneering work includes:

• Rethink Connects: Peer Support for Young Women with Breast Cancer, which provides free and confidential telephone and email support across Canada
• Your Man Reminder, an internationally acclaimed breast health awareness campaign
• Canada’s first qualitative survey about the experiences of young women with breast cancer and accompanying report: Breast Cancer in Young Women in Canada: A Needs Assessment
• Advocacy for greater access to evidenced based treatments and diagnostic testing to empower young women facing breast cancer to make more personalized treatment decisions.

For more information about Rethink Breast Cancer or to make a contribution to help support the innovative work we do to meet the unique needs of young women facing breast cancer as well as our ongoing education and advocacy campaigns, please visit www.rethinkbreastcancer.com.

***
CO Twitter Banner Ad
***
InPress-CON

Volume 20, Number 5 (October 2013)

The latest issue of Current Oncology is now available online. Please visit the following link to view full text articles from this issue:
http://www.current-oncology.com/index.php/oncology/issue/current/showToc

***
LookingAhead-CON

Upcoming in Current Oncology

The future table of contents for Current Oncology, Volume 20, Number 6 (December 2013) is now available. For the most up-to-date listing of scheduled papers, please visit the following link:
http://www.current-oncology.com/index.php/oncology/about/futureTOC

***
EditorSpotlight
MKT 9759

Dr. Daniel Rayson, MD, FRCPC, FACP
Editor of our Cancer Narratives Section (since January 2013)

Dr. Daniel Rayson is a medical oncologist at the Queen Elizabeth II Health Sciences Centre and Professor of Medicine and Pediatrics at Dalhousie University. He completed his medical training at Dalhousie and completed training in Internal Medicine and Hematology/Medical Oncology at the Mayo Clinic in Rochester, Minnesota.

His main areas of clinical care and research activities are in breast and gastrointestinal neuroendocrine oncology, with interests in cancer genetics, clinical trial development and health services and translational research.

He is past Chair of the Nova Scotia Provincial Breast Cancer Site Team (2000-2009) and the Clinical Trial Grant Panel Review Committee of the National Cancer Institute of Canada (2006-2009). In February 2008, he was appointed Director of the Atlantic Clinical Cancer Research Unit (ACCRU) and is a founding board member of the Beatrice Hunter Cancer Research Institute (BHCRI). He is on the editorial board for the Art of Oncology Section of the Journal of Clinical Oncology and has been section editor of the Cancer Narratives Section of Current Oncology since January, 2013.

***
HaveYouHeard-CON

Current Oncology Welcomes a New Member to our Editorial Team

We are pleased to announce the following new member to the Current Oncology Editorial team:

• Dr. Nicole Beauchemin, Rosalind and Morris Goodman Cancer Research Centre, Montreal, QC (Section Editor, Biomarkers in Oncology)

***
ReadersChoice-COn

Have you had the chance to view these Current Oncology “Most-Read” articles?

Most Read Articles in PubMed Central (September 2013)

Legalizing euthanasia or assisted suicide: the illusion of safeguards and controls
Pereira J.
Curr Oncol. 2011 Apr;18(2):e38-45

Management of skin rash during EGFR-targeted monoclonal antibody treatment for gastrointestinal malignancies: Canadian recommendations
Melosky B, Burkes R, Rayson D, Alcindor T, Shear N, Lacouture M
Curr Oncol. 2009 Jan;16(1):16-26

Prophylaxis and management of acute radiation-induced skin reactions: a systematic review of the literature
Salvo N, Barnes E, van Draanen J, Stacey E, Mitera G, Breen D, Giotis A, Czarnota G, Pang J, De Angelis C.
Curr Oncol. 2010 Aug;17(4):94-112

Most Read Recently* Published Articles at www.current-oncology.com

Lenalidomide in multiple myeloma – a practice guideline
Chen C., Baldassarre F., Kanjeekal S., Herst J., Hicks L., Cheung M.
Curr Oncol. 2013 Apr;20(2): e136-149

Targeting the androgen receptor in the management of castration-resistant prostate cancer: rationale, progress, and future directions
Leibowitz–Amit R., Joshua A.
Curr Oncol. 2012 Dec;19(Supplement 3): e244-257

Endocrine therapy for postmenopausal women with hormone receptor–positive her2–negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: a Canadian consensus statement
Pritchard K.I., Gelmon K.A., Rayson D., Provencher L., Webster M., McLeod D., Verma S.
Curr Oncol. 2013 Feb;20(1):48-61

*Published within past 12 months

***
QuickLinks-CON
***

Contact Us

Email-CON
 
Address-CON
 
Phone-CON
 
Web-CON
twitter
1px